Gene-based Advanced Therapy Medicinal Market Report – Research, Industry Analysis Reports and Market Demands

Global Gene-based Advanced Therapy Medicinal Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene-based Advanced Therapy Medicinal by Type
- 1.3.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Gene-based Advanced Therapy Medicinal Consumption Value Market Share by Type in 2024
- 1.3.3 Viral Gene Delivery System
- 1.3.4 Non-viral Gene Delivery System
1.4 Global Gene-based Advanced Therapy Medicinal Market by Application
- 1.4.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Neurological Diseases
- 1.4.3 Cancer
- 1.4.4 Other
1.5 Global Gene-based Advanced Therapy Medicinal Market Size & Forecast
1.6 Global Gene-based Advanced Therapy Medicinal Market Size and Forecast by Region
- 1.6.1 Global Gene-based Advanced Therapy Medicinal Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Gene-based Advanced Therapy Medicinal Market Size by Region, (2020-2031)
- 1.6.3 North America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2020-2031)
- 1.6.4 Europe Gene-based Advanced Therapy Medicinal Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size and Prospect (2020-2031)
- 1.6.6 South America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size and Prospect (2020-2031)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Gene-based Advanced Therapy Medicinal Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Gene-based Advanced Therapy Medicinal by Company Revenue
- 3.2.2 Top 3 Gene-based Advanced Therapy Medicinal Players Market Share in 2024
- 3.2.3 Top 6 Gene-based Advanced Therapy Medicinal Players Market Share in 2024
3.3 Gene-based Advanced Therapy Medicinal Market: Overall Company Footprint Analysis
- 3.3.1 Gene-based Advanced Therapy Medicinal Market: Region Footprint
- 3.3.2 Gene-based Advanced Therapy Medicinal Market: Company Product Type Footprint
- 3.3.3 Gene-based Advanced Therapy Medicinal Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Gene-based Advanced Therapy Medicinal Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

5.1 Global Gene-based Advanced Therapy Medicinal Consumption Value Market Share by Application (2020-2025)
5.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Application (2026-2031)

6 North America

6.1 North America Gene-based Advanced Therapy Medicinal Consumption Value by Type (2020-2031)
6.2 North America Gene-based Advanced Therapy Medicinal Market Size by Application (2020-2031)
6.3 North America Gene-based Advanced Therapy Medicinal Market Size by Country
- 6.3.1 North America Gene-based Advanced Therapy Medicinal Consumption Value by Country (2020-2031)
- 6.3.2 United States Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)

7 Europe

7.1 Europe Gene-based Advanced Therapy Medicinal Consumption Value by Type (2020-2031)
7.2 Europe Gene-based Advanced Therapy Medicinal Consumption Value by Application (2020-2031)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Country
- 7.3.1 Europe Gene-based Advanced Therapy Medicinal Consumption Value by Country (2020-2031)
- 7.3.2 Germany Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 7.3.3 France Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 7.3.5 Russia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 7.3.6 Italy Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)

8 Asia-Pacific

8.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gene-based Advanced Therapy Medicinal Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region
- 8.3.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Consumption Value by Region (2020-2031)
- 8.3.2 China Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 8.3.3 Japan Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 8.3.5 India Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 8.3.7 Australia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)

9 South America

9.1 South America Gene-based Advanced Therapy Medicinal Consumption Value by Type (2020-2031)
9.2 South America Gene-based Advanced Therapy Medicinal Consumption Value by Application (2020-2031)
9.3 South America Gene-based Advanced Therapy Medicinal Market Size by Country
- 9.3.1 South America Gene-based Advanced Therapy Medicinal Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)

10 Middle East & Africa

10.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country
- 10.3.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)
- 10.3.4 UAE Gene-based Advanced Therapy Medicinal Market Size and Forecast (2020-2031)

11 Market Dynamics

11.1 Gene-based Advanced Therapy Medicinal Market Drivers
11.2 Gene-based Advanced Therapy Medicinal Market Restraints
11.3 Gene-based Advanced Therapy Medicinal Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Gene-based Advanced Therapy Medicinal Industry Chain
12.2 Gene-based Advanced Therapy Medicinal Upstream Analysis
12.3 Gene-based Advanced Therapy Medicinal Midstream Analysis
12.4 Gene-based Advanced Therapy Medicinal Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Gene-based Advanced Therapy Medicinal market size was valued at US$ 14080 million in 2024 and is forecast to a readjusted size of USD 48880 million by 2031 with a CAGR of 19.7% during review period.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report is a detailed and comprehensive analysis for global Gene-based Advanced Therapy Medicinal market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene-based Advanced Therapy Medicinal market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene-based Advanced Therapy Medicinal market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene-based Advanced Therapy Medicinal market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene-based Advanced Therapy Medicinal market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene-based Advanced Therapy Medicinal
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene-based Advanced Therapy Medicinal market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene-based Advanced Therapy Medicinal market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segment by Application
Neurological Diseases
Cancer
Other
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene-based Advanced Therapy Medicinal product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene-based Advanced Therapy Medicinal, with revenue, gross margin, and global market share of Gene-based Advanced Therapy Medicinal from 2020 to 2025.
Chapter 3, the Gene-based Advanced Therapy Medicinal competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene-based Advanced Therapy Medicinal market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene-based Advanced Therapy Medicinal.
Chapter 13, to describe Gene-based Advanced Therapy Medicinal research findings and conclusion.

Buy now